Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-21-032076)

Filing Details

Accession Number:: 0001209191-21-032076
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-12 13:00:00
Reporting Period:: 2021-05-10

Accepted Time:: 2021-05-12 16:45:42
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1624658	Allena Pharmaceuticals Inc.	ALNA	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1389500	Md Louis Brenner	C/O Allena Pharmaceuticals, Inc. One Newton Executive Park, Suite 202 Newton MA 02462	President And Coo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-05-10	25,215	$1.11	203,322	No	4	S	Direct
Common Stock	Acquisiton	2021-05-10	83,721	$0.00	228,537	No	4	M	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	M	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2021-05-10	83,721	$0.00	83,721	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
125,582			No	4	M	Direct

Footnotes

The sale reported on this Form 4 was effected by the Reporting Person and represents shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
Each restricted stock unit represents a contingent right to receive one share of common stock.
40% shall vest on May 10, 2021 and the remaining 60% shall vest on November 10, 2021, subject to the Reporting Person's continued service through each vesting date.